Intrinsiqq

Pharma Mar, S.A. (PHM.XMAD) Dividend Analysis

Does Pharma Mar (PHM.XMAD) pay a dividend?

No. Pharma Mar (PHM.XMAD) paid €1.00 per share in fiscal 2025 and has paid nothing in the last twelve months.

Computed from company filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.

Dividend per share by fiscal year
Fiscal yearPer shareChange
2025€1.00+25.0%
2024€0.80+23.1%
2023€0.650.0%
2022€0.650.0%
2021€0.65

All 5 fiscal years we hold. Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.

PHM.XMAD
Dividend39
No current dividend

Earnings payout ratio is moderate, no sustained growth pattern yet.

Based on TTM and annual data · Not a buy/sell signal

Score Breakdown

50

Safety

40% of composite

Earnings Payout100
0.0%Well-covered
FCF Coverage0
N/ANo data
53

Growth

35% of composite

Dividend Streak20
2YNo sustained streak
Growth Rate85
11.4%Strong compounder
0

Income

25% of composite

Cash Yield (TTM)0
N/ANo data

Composite = Safety (50) × 0.40 + Growth (53) × 0.35 + Income (0) × 0.25 = 39

Dividend Yield

—

Per Share (TTM)

€0.00

Payout Ratio

0.0%

4Y CAGR

11.4%

Dividend Safety

Earnings Payout

0.0%

FCF Payout

0.0%

FCF Coverage

—

Dividend Growth

Per Share (TTM)

€0.00

Growth Streak

2 years

4Y CAGR

11.4%

Yield History

Does Pharma Mar (PHM.XMAD) pay a dividend?

Frequently asked

Does Pharma Mar (PHM.XMAD) pay a dividend?+

No. Pharma Mar (PHM.XMAD) does not currently pay a dividend. The last payment in our data was in 2025, and nothing has been paid since.

How does Pharma Mar return cash to shareholders?+

It largely does not. Pharma Mar pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.

Could Pharma Mar afford to pay a dividend?+

On the numbers, yes. Pharma Mar generated €51 million of free cash flow, which is about €2.95 per share. If it paid out half of that, the dividend would be roughly €1.48 per share, a yield of about 2.2% at the current price. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.

Which healthcare companies do pay dividends?+

Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Pharma Mar.

Related stocks: Biotechnology

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.